Tag Archives: PDE5 inhibitors

Avanafil Approval from the FDA Gives ED Treatment a New Name

Male penile impotence or erectile dysfunction (ED) is a male sexual condition wherein a man is unable to produce a useable erection for sexual intercourse.  There are many factors that cause this condition and all of them essentially inhibit men from having sex.  Sex is a very important activity for men and without it practically makes their manhood of no use.  Additionally, sex is very important for intimate activity between lovers and if this condition leaves the female dissatisfied, it may lead to infidelity or even relationship breakups.  Fortunately, highly efficient and effective ED medications are available.  The latest ED drug, avanafil, has been approved by the FDA of America as a treatment for erectile dysfunction.

Avanafil approval from the FDA is not lame feat because this drug has undergone through extensive research and development to get this avanafil approval.  In short, FDA’s avanafil approval is not a fluke and this avanafil approval is a well-deserved acknowledgement for the drug classification it belongs to which is PDE5 inhibitors.  This classification of drugs is also the same classification where the popular ED drug, Viagra, belongs to.  While it has been more than a decade since the release of Viagra prior to the FDA’s avanafil approval, the latter nevertheless is very much capable of competing with the big boys of ED treatment as avanafil is also very much effective in treating ED issues and that gaining avanafil approval is an acknowledgement that is very much highly regarded by the users. Continue reading